A new antibody associated with squamous cell carcinoma, YM-Antibody, containing components of pl 5. 95-6. 10 fractions, was produced from cell cultures of squamous cell carcinoma of the larynx.
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To elucidate the immunological characteristics of YM-Antibody, it and 6 other commercially available antibodies were investigated immunohistochemically by applying them to squamous cell carcinomas and non-malignant tissues obtained from various regions of the head and neck.
The results showed high positivity of YM -Antibody (85. 0%) on squamous cell carcinoma and extremely low false-positivity (10. 5%) on non-malignant tissue. These finding suggest that the diagnostic efficacy of this YM-Antibody is 76. 2%, while that of the other antibodies was less than 50%.
The YM-Antibody will be useful as a diagnostic tool for squamous cell carcinoma of the head and neck. 
